Shanghai Yizhong Pharmaceutical Co., Ltd.
Status: Publicly traded
Direct answer
Shanghai Yizhong Pharmaceutical Co., Ltd. is publicly traded on SHH under the ticker 688091.SS.
Shanghai Yizhong Pharmaceutical Co., Ltd. engages in the development of anti-tumor drugs and related products in China. It also offers paclitaxel polymer nanomicelles for the treatment of non-small cell lung cancer, as well as various types of cancer, including esophageal cancer, gastric cancer, nasopharyngeal carcinoma, pancreatic cancer, breast cancer, gynecological tumors, etc. The company was founded in 2009 and...
Can you invest in Shanghai Yizhong Pharmaceutical Co., Ltd.?
Yes. Shanghai Yizhong Pharmaceutical Co., Ltd. trades publicly on SHH as 688091.SS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Shanghai Yizhong Pharmaceutical Co., Ltd.
Detailed equity research is provided by MarketSnap.